Corcept Therapeutics Incorporated is a pharmaceutical company that develops and markets medicines that modulate the hormone cortisol. Its main commercial product is used to treat patients with Cushing's syndrome, a condition caused by excess cortisol, and the company also studies additional cortisol-modulating compounds for other serious endocrine and stress-related conditions. Corcept works with physicians and patients in the United States and is headquartered in Menlo Park, California.
Corcept Therapeutics Incorporated trades under the code 0I3Q on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1361 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
92/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average58.7%
From 52-week high-5.9%
MomentumStrong
95/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return24.2%
6-month return161.7%
Stability (higher is calmer)Weak
8/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)100.7%
Worst drawdown, 1 year (smaller is calmer)-63.7%
LiquidityWeak
32/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.12M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 28.67 – 126.57Daily closes, split-adjusted
Signals
50-day average115.79
200-day average72.99
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.66
Technical summary
Daily
Bullish
7 bullish · 4 neutral · 4 bearish
Weekly
Strongly bullish
6 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
1 bullish · 0 neutral · 0 bearish
Moving averages (daily)
SMA 10
117.0
Bearish
EMA 10
115.6
Bullish
SMA 20
116.4
Bearish
EMA 20
115.9
Bearish
SMA 50
115.8
Bullish
EMA 50
112.4
Bullish
SMA 100
103.0
Bullish
EMA 100
101.8
Bullish
SMA 200
72.99
Bullish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
50.34
Neutral
MACD (12, 26)
0.11
Bullish
Momentum (12)
-0.41
Bearish
Stochastic %K (14)
50.95
Neutral
Williams %R (14)
-49.05
Neutral
CCI (20)
-57.20
Neutral
Pivot points (classic, last session)
S3
105.3
S2
107.8
S1
111.8
Pivot
114.4
R1
118.4
R2
120.9
R3
124.9
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
